米国創傷ケア市場規模・シェア・動向分析レポート:製品別(先進創傷被覆材、外科用創傷ケア、従来型創傷ケア)、用途別、最終用途別、購入形態別、流通チャネル別、セグメント別予測、2024〜2030年U.S. Wound Care Market Size, Share & Trends Analysis Report By Product (Advanced Wound Dressing, Surgical Wound Care, Traditional Wound Care), By Application, By End-use, By Mode Of Purchase, Distribution Channel, And Segment Forecasts, 2024 - 2030 米国創傷ケア市場の成長と動向 Grand View Research社の最新レポートによると、米国の創傷ケア市場規模は2030年までに114億2000万米ドルに達すると予測されている。2024年から2030年にかけての年平均成長率は4... もっと見る
1~3営業日
サマリー米国創傷ケア市場の成長と動向Grand View Research社の最新レポートによると、米国の創傷ケア市場規模は2030年までに114億2000万米ドルに達すると予測されている。2024年から2030年にかけての年平均成長率は4.11%と予測されている。事故件数の増加、老人人口の増加、外来手術センター(ASC)の増加。また、医療技術の急速な進歩も市場成長の主な要因である。 糖尿病や末梢血管疾患(静脈性高血圧、動脈不全)など、皮膚の完全性に影響を及ぼす慢性疾患の有病率は、老人人口の増加とともに増加している。皮膚の破壊、潰瘍化、慢性的な爛れの形成は、これらの疾患の一般的な結果である。さらに、高齢者は免疫力が低下しており、感染症のリスクが高いため、創傷治療が難しくなっている。そのため、特に重度の創傷の場合、高度な創傷ケアソリューションの必要性が高まる。そのため、高度な創傷ケア製品のニーズが高まっている。例えば、United Health Foundationによると、2023年5月に米国に住む65歳以上の成人は5,580万人を超え、全米人口の約16.8%を占める。こうした要因が、予測期間中の市場成長を押し上げると予想される。 抗菌剤耐性、不健康で座りがちなライフスタイル、アルコールやタバコの使用などは、非感染性疾患の有病率を上昇させている要因の一部である。例えば、2022年12月、CDCは、米国の成人の10人に6人が現在、がん、心臓病、糖尿病などの慢性疾患を抱えて生活していると推定した。さらに、全米慢性疾患担当者協会によると、2022年には成人アメリカ人の60%近くが少なくとも1つの慢性疾患を抱えているという。これらの上記の要因は、予測期間中の市場成長を促進すると予想される。 米国創傷ケア市場レポートハイライト - 製品別では、糖尿病患者の増加により、高度創傷被覆材分野が2023年に最大のシェアを占めた。 - 用途別では、糖尿病と糖尿病性足潰瘍の増加により、慢性創傷分野が2023年に最も高いシェアを占めた。 - 病院セグメントは、慢性創傷の発生率の増加、手術件数の増加、高齢化人口の増加により、2023年の最終用途市場全体で最大のシェアを占めた。 - Health Policy Instituteによると、米国では約66%が処方箋医薬品を消費しているためである。 - 販売チャネル別では、高度創傷治療用製品の大半が病院やその他の医療施設などさまざまな環境で直接販売されていることから、2023年の市場は施設販売セグメントが最も高いシェアを占めた。 目次Table of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Product 1.1.2. Application 1.1.3. End-use 1.1.4. Mode of purchase 1.1.5. Distribution channel 1.1.6. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.3.5.1. Data for primary interviews in North America 1.3.5.2. Data for primary interviews in Europe 1.3.5.3. Data for primary interviews in Asia Pacific 1.3.5.4. Data for primary interviews in Latin America 1.3.5.5. Data for Primary interviews in MEA 1.4. Information or Data Analysis 1.4.1. Data analysis models 1.5. Market Formulation & Validation 1.6. Model Details 1.6.1. Commodity flow analysis (Model 1) 1.6.1.1. Approach 1: Commodity flow approach 1.6.2. Volume price analysis (Model 2) 1.6.2.1. Approach 2: Volume price analysis 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives 1.9.1. Objective 1 1.9.2. Objective 2 Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Product outlook 2.2.2. Application outlook 2.2.3. End-use outlook 2.2.4. Mode of purchase outlook 2.2.5. Distribution channel outlook 2.3. Competitive Insights Chapter 3. U.S. Wound Care Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Market Dynamics 3.2.1. Market driver analysis 3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities 3.2.1.2. Introduction of innovative and advanced wound products 3.2.1.3. Rising geriatric population 3.2.1.4. Increasing number of ambulatory surgical centers (ASCs) 3.2.1.5. Increasing number of accidents 3.2.1.6. Steep rise in the number of hospitals & urgent care centers and an increase in hospital admissions 3.2.1.7. Improvements in public and private hospital infrastructure 3.2.2. Market restraint analysis 3.2.2.1. Stringent manufacturing policies 3.2.2.2. High cost of advanced wound care products and chronic wound treatments 3.2.3. Market opportunity analysis 3.3. U.S. Wound Care Market Analysis Tools 3.3.1. Industry Analysis - Porter’s 3.3.1.1. Supplier power 3.3.1.2. Buyer power 3.3.1.3. Substitution threat 3.3.1.4. Threat of new entrant 3.3.1.5. Competitive rivalry 3.3.2. PESTEL Analysis 3.3.2.1. Political landscape 3.3.2.2. Technological landscape 3.3.2.3. Economic landscape 3.3.3. Covid-19 Impact Analysis Chapter 4. U.S. Wound Care Market: Product Estimates & Trend Analysis 4.1. Definitions and Scope 4.1.1. Advanced wound dressing 4.1.2. Surgical wound care 4.1.3. Traditional wound care 4.1.4. Wound therapy devices 4.2. Product Market Share, 2018 & 2030 4.3. Segment Dashboard 4.4. U.S. Wound Care Market by Product Outlook 4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following 4.5.1. Advanced wound dressing 4.5.1.1. Advanced wound dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.2. Foam dressings 4.5.1.2.1. Foam dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.3. Hydrocolloid dressings 4.5.1.3.1. Hydrocolloid dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.4. Film dressings 4.5.1.4.1. Film dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.5. Alginate dressings 4.5.1.5.1. Alginate dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.6. Hydrogel dressings 4.5.1.6.1. Hydrogel dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.7. Collagen dressings 4.5.1.7.1. Collagen dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.8. Other advanced dressings 4.5.1.8.1. Other advanced dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.2. Surgical wound care 4.5.2.1. Surgical wound care market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.2. Sutures & staples 4.5.2.2.1. Sutures & staples market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.3. Tissue adhesives & sealants 4.5.2.3.1. Tissue adhesives & sealants market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.4. Anti-infective dressing 4.5.2.4.1. Anti-infective dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.3. Traditional wound care 4.5.3.1. Traditional wound care market estimates and forecast 2018 to 2030 (USD Million) 4.5.3.2. Medical tapes 4.5.3.2.1. Medical tapes market estimates and forecast 2018 to 2030 (USD Million) 4.5.3.3. Cotton 4.5.3.3.1. Cotton market estimates and forecast 2018 to 2030 (USD Million) 4.5.3.4. Bandages 4.5.3.4.1. Bandages market estimates and forecast 2018 to 2030 (USD Million) 4.5.3.5. Gauzes 4.5.3.5.1. Gauzes market estimates and forecast 2018 to 2030 (USD Million) 4.5.3.6. Sponges 4.5.3.6.1. Sponges market estimates and forecast 2018 to 2030 (USD Million) 4.5.3.7. Cleansing agents 4.5.3.7.1. Cleansing agents market estimates and forecast 2018 to 2030 (USD Million) 4.5.4. Wound therapy devices 4.5.4.1. Wound therapy devices market estimates and forecast 2018 to 2030s, (USD Million) 4.5.4.2. Negative pressure wound therapy 4.5.4.2.1. Negative pressure wound therapy market estimates and forecast 2018 to 2030 (USD Million) 4.5.4.3. Oxygen and hyperbaric oxygen equipment 4.5.4.3.1. Oxygen and hyperbaric oxygen equipment market estimates and forecast 2018 to 2030 (USD Million) 4.5.4.4. Electric stimulation devices 4.5.4.4.1. Electric stimulation devices market estimates and forecast 2018 to 2030 (USD Million) 4.5.4.5. Pressure relief devices 4.5.4.5.1. Pressure relief devices market estimates and forecast 2018 to 2030 (USD Million) 4.5.4.6. Others 4.5.4.6.1. Others market estimates and forecast 2018 to 2030 (USD Million) Chapter 5. U.S. Wound Care Market: Application Estimates & Trend Analysis 5.1. Definitions and Scope 5.1.1. Acute Wounds 5.1.2. Chronic Wounds 5.2. Application Market Share, 2018 & 2030 5.3. Segment Dashboard 5.4. U.S. Wound Care Market by Application Outlook 5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following 5.5.1. Acute Wounds 5.5.1.1. Acute wounds market estimates and forecast 2018 to 2030 (USD Million) 5.5.1.2. Surgical & traumatic wounds 5.5.1.2.1. Surgical & traumatic wounds market estimates and forecast 2018 to 2030 (USD Million) 5.5.1.3. Burns 5.5.1.3.1. Burns market estimates and forecast 2018 to 2030 (USD Million) 5.5.2. Chronic Wounds 5.5.2.1. Chronic wounds market estimates and forecast 2018 to 2030 (USD Million) 5.5.2.2. Diabetic foot ulcers 5.5.2.2.1. Diabetic foot ulcers market estimates and forecast 2018 to 2030 (USD Million) 5.5.2.3. Pressure ulcers 5.5.2.3.1. Pressure ulcers market estimates and forecast 2018 to 2030 (USD Million) 5.5.2.4. Venous leg ulcers 5.5.2.4.1. Venous leg ulcers market estimates and forecast 2018 to 2030 (USD Million) 5.5.2.5. Others chronic wounds 5.5.2.5.1. Others chronic wounds market estimates and forecast 2018 to 2030 (USD Million) Chapter 6. U.S. Wound Care Devices: End-Use Estimates & Trend Analysis 6.1. Definitions and Scope 6.1.1. Hospitals 6.1.2. Outpatient facilities 6.1.3. Home care 6.1.4. Research & manufacturing 6.2. End Use Market Share, 2018 & 2030 6.3. Segment Dashboard 6.4. U.S. Wound Care Market by End-use Outlook 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 6.5.1. Hospitals 6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million) 6.5.2. Outpatient facilities 6.5.2.1. Outpatient facilities centers market estimates and forecast 2018 to 2030 (USD Million) 6.5.3. Home care 6.5.3.1. Home care market estimates and forecast 2018 to 2030 (USD Million) 6.5.4. Research & manufacturing 6.5.4.1. Research & manufacturing market estimates and forecast 2018 to 2030 (USD Million) Chapter 7. U.S. Wound Care Devices: Mode of Purchase Estimates & Trend Analysis 7.1. Definitions and Scope 7.1.1. Prescribed 7.1.2. Non-prescribed (OTC) 7.2. Mode of Purchase Market Share, 2018 & 2030 7.3. Segment Dashboard 7.4. U.S. Wound Care Market by Mode of Purchase Outlook 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 7.5.1. Prescribed 7.5.1.1. Prescribed market estimates and forecast 2018 to 2030 (USD Million) 7.5.2. Non-prescribed (OTC) 7.5.2.1. Non-prescribed (OTC) market estimates and forecast 2018 to 2030 (USD Million) Chapter 8. U.S. Wound Care Devices: Distribution Channel Estimates & Trend Analysis 8.1. Definitions and Scope 8.1.1. Institutional sales 8.1.2. Retail sales 8.2. Distribution Channel Market Share, 2018 & 2030 8.3. Segment Dashboard 8.4. U.S. Wound Care Market by Distribution Channel Outlook 8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 8.5.1. Institutional sales 8.5.1.1. Institutional sales market estimates and forecast 2018 to 2030 (USD Million) 8.5.2. Retail sales 8.5.2.1. Retail sales market estimates and forecast 2018 to 2030 (USD Million) Chapter 9. Competitive Landscape 9.1. Recent Developments & Impact Analysis, By Key Market Participants 9.2. Company/Competition Categorization 9.2.1. Innovators 9.3. Vendor Landscape 9.3.1. List of key distributors and channel partners 9.3.2. Key customers 9.3.3. Key company market share analysis, 2023 9.3.4. Smith & Nephew PLC 9.3.4.1. Company overview 9.3.4.2. Financial performance 9.3.4.3. Product benchmarking 9.3.4.4. Strategic initiatives 9.3.5. Mölnlycke Health Care AB 9.3.5.1. Company overview 9.3.5.2. Financial performance 9.3.5.3. Product benchmarking 9.3.5.4. Strategic initiatives 9.3.6. ConvaTec Group PLC 9.3.6.1. Company overview 9.3.6.2. Financial performance 9.3.6.3. Product benchmarking 9.3.6.4. Strategic initiatives 9.3.7. Baxter International 9.3.7.1. Company overview 9.3.7.2. Financial performance 9.3.7.3. Product benchmarking 9.3.7.4. Strategic initiatives 9.3.8. URGO Medical 9.3.8.1. Financial performance 9.3.8.2. Product benchmarking 9.3.8.3. Strategic initiatives 9.3.9. Coloplast Corp. 9.3.9.1. Company overview 9.3.9.2. Financial performance 9.3.9.3. Product benchmarking 9.3.9.4. Strategic initiatives 9.3.10. Medtronic 9.3.10.1. Company overview 9.3.10.2. Financial performance 9.3.10.3. Product benchmarking 9.3.10.4. Strategic initiatives 9.3.11. 3M 9.3.11.1. Company overview 9.3.11.2. Financial performance 9.3.11.3. Product benchmarking 9.3.11.4. Strategic initiatives 9.3.12. Derma Sciences (Integra LifeSciences) 9.3.12.1. Company overview 9.3.12.2. Financial performance 9.3.12.3. Product benchmarking 9.3.12.4. Strategic initiatives 9.3.13. Medline Industries, Inc. 9.3.13.1. Company overview 9.3.13.2. Financial performance 9.3.13.3. Product benchmarking 9.3.13.4. Strategic initiatives 9.3.14. 3M 9.3.14.1. Company overview 9.3.14.2. Financial performance 9.3.14.3. Product benchmarking 9.3.14.4. Strategic initiatives 9.3.15. Ethicon (Johnson & Johnson) 9.3.15.1. Company overview 9.3.15.2. Financial performance 9.3.15.3. Product benchmarking 9.3.15.4. Strategic initiatives 9.3.16. B. Braun SE 9.3.16.1. Company overview 9.3.16.2. Financial performance 9.3.16.3. Product benchmarking 9.3.16.4. Strategic initiatives 9.3.17. Cardinal Health, Inc. 9.3.17.1. Company overview 9.3.17.2. Financial performance 9.3.17.3. Product benchmarking 9.3.17.4. Strategic initiatives 9.3.18. Organogenesis Inc 9.3.18.1. Company overview 9.3.18.2. Financial performance 9.3.18.3. Product benchmarking 9.3.18.4. Strategic initiatives 9.3.19. MIMEDX Group, Inc. 9.3.19.1. Company overview 9.3.19.2. Financial performance 9.3.19.3. Product benchmarking 9.3.19.4. Strategic initiatives
SummaryU.S. Wound Care Market Growth & Trends Table of ContentsTable of ContentsChapter 1. Methodology and Scope 1.1. Market Segmentation & Scope 1.1.1. Product 1.1.2. Application 1.1.3. End-use 1.1.4. Mode of purchase 1.1.5. Distribution channel 1.1.6. Estimates and forecast timeline 1.2. Research Methodology 1.3. Information Procurement 1.3.1. Purchased database 1.3.2. GVR’s internal database 1.3.3. Secondary sources 1.3.4. Primary research 1.3.5. Details of primary research 1.3.5.1. Data for primary interviews in North America 1.3.5.2. Data for primary interviews in Europe 1.3.5.3. Data for primary interviews in Asia Pacific 1.3.5.4. Data for primary interviews in Latin America 1.3.5.5. Data for Primary interviews in MEA 1.4. Information or Data Analysis 1.4.1. Data analysis models 1.5. Market Formulation & Validation 1.6. Model Details 1.6.1. Commodity flow analysis (Model 1) 1.6.1.1. Approach 1: Commodity flow approach 1.6.2. Volume price analysis (Model 2) 1.6.2.1. Approach 2: Volume price analysis 1.7. List of Secondary Sources 1.8. List of Primary Sources 1.9. Objectives 1.9.1. Objective 1 1.9.2. Objective 2 Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.2.1. Product outlook 2.2.2. Application outlook 2.2.3. End-use outlook 2.2.4. Mode of purchase outlook 2.2.5. Distribution channel outlook 2.3. Competitive Insights Chapter 3. U.S. Wound Care Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent market outlook 3.1.2. Related/ancillary market outlook 3.2. Market Dynamics 3.2.1. Market driver analysis 3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities 3.2.1.2. Introduction of innovative and advanced wound products 3.2.1.3. Rising geriatric population 3.2.1.4. Increasing number of ambulatory surgical centers (ASCs) 3.2.1.5. Increasing number of accidents 3.2.1.6. Steep rise in the number of hospitals & urgent care centers and an increase in hospital admissions 3.2.1.7. Improvements in public and private hospital infrastructure 3.2.2. Market restraint analysis 3.2.2.1. Stringent manufacturing policies 3.2.2.2. High cost of advanced wound care products and chronic wound treatments 3.2.3. Market opportunity analysis 3.3. U.S. Wound Care Market Analysis Tools 3.3.1. Industry Analysis - Porter’s 3.3.1.1. Supplier power 3.3.1.2. Buyer power 3.3.1.3. Substitution threat 3.3.1.4. Threat of new entrant 3.3.1.5. Competitive rivalry 3.3.2. PESTEL Analysis 3.3.2.1. Political landscape 3.3.2.2. Technological landscape 3.3.2.3. Economic landscape 3.3.3. Covid-19 Impact Analysis Chapter 4. U.S. Wound Care Market: Product Estimates & Trend Analysis 4.1. Definitions and Scope 4.1.1. Advanced wound dressing 4.1.2. Surgical wound care 4.1.3. Traditional wound care 4.1.4. Wound therapy devices 4.2. Product Market Share, 2018 & 2030 4.3. Segment Dashboard 4.4. U.S. Wound Care Market by Product Outlook 4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following 4.5.1. Advanced wound dressing 4.5.1.1. Advanced wound dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.2. Foam dressings 4.5.1.2.1. Foam dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.3. Hydrocolloid dressings 4.5.1.3.1. Hydrocolloid dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.4. Film dressings 4.5.1.4.1. Film dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.5. Alginate dressings 4.5.1.5.1. Alginate dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.6. Hydrogel dressings 4.5.1.6.1. Hydrogel dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.7. Collagen dressings 4.5.1.7.1. Collagen dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.1.8. Other advanced dressings 4.5.1.8.1. Other advanced dressings market estimates and forecast 2018 to 2030 (USD Million) 4.5.2. Surgical wound care 4.5.2.1. Surgical wound care market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.2. Sutures & staples 4.5.2.2.1. Sutures & staples market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.3. Tissue adhesives & sealants 4.5.2.3.1. Tissue adhesives & sealants market estimates and forecast 2018 to 2030 (USD Million) 4.5.2.4. Anti-infective dressing 4.5.2.4.1. Anti-infective dressing market estimates and forecast 2018 to 2030 (USD Million) 4.5.3. Traditional wound care 4.5.3.1. Traditional wound care market estimates and forecast 2018 to 2030 (USD Million) 4.5.3.2. Medical tapes 4.5.3.2.1. Medical tapes market estimates and forecast 2018 to 2030 (USD Million) 4.5.3.3. Cotton 4.5.3.3.1. Cotton market estimates and forecast 2018 to 2030 (USD Million) 4.5.3.4. Bandages 4.5.3.4.1. Bandages market estimates and forecast 2018 to 2030 (USD Million) 4.5.3.5. Gauzes 4.5.3.5.1. Gauzes market estimates and forecast 2018 to 2030 (USD Million) 4.5.3.6. Sponges 4.5.3.6.1. Sponges market estimates and forecast 2018 to 2030 (USD Million) 4.5.3.7. Cleansing agents 4.5.3.7.1. Cleansing agents market estimates and forecast 2018 to 2030 (USD Million) 4.5.4. Wound therapy devices 4.5.4.1. Wound therapy devices market estimates and forecast 2018 to 2030s, (USD Million) 4.5.4.2. Negative pressure wound therapy 4.5.4.2.1. Negative pressure wound therapy market estimates and forecast 2018 to 2030 (USD Million) 4.5.4.3. Oxygen and hyperbaric oxygen equipment 4.5.4.3.1. Oxygen and hyperbaric oxygen equipment market estimates and forecast 2018 to 2030 (USD Million) 4.5.4.4. Electric stimulation devices 4.5.4.4.1. Electric stimulation devices market estimates and forecast 2018 to 2030 (USD Million) 4.5.4.5. Pressure relief devices 4.5.4.5.1. Pressure relief devices market estimates and forecast 2018 to 2030 (USD Million) 4.5.4.6. Others 4.5.4.6.1. Others market estimates and forecast 2018 to 2030 (USD Million) Chapter 5. U.S. Wound Care Market: Application Estimates & Trend Analysis 5.1. Definitions and Scope 5.1.1. Acute Wounds 5.1.2. Chronic Wounds 5.2. Application Market Share, 2018 & 2030 5.3. Segment Dashboard 5.4. U.S. Wound Care Market by Application Outlook 5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following 5.5.1. Acute Wounds 5.5.1.1. Acute wounds market estimates and forecast 2018 to 2030 (USD Million) 5.5.1.2. Surgical & traumatic wounds 5.5.1.2.1. Surgical & traumatic wounds market estimates and forecast 2018 to 2030 (USD Million) 5.5.1.3. Burns 5.5.1.3.1. Burns market estimates and forecast 2018 to 2030 (USD Million) 5.5.2. Chronic Wounds 5.5.2.1. Chronic wounds market estimates and forecast 2018 to 2030 (USD Million) 5.5.2.2. Diabetic foot ulcers 5.5.2.2.1. Diabetic foot ulcers market estimates and forecast 2018 to 2030 (USD Million) 5.5.2.3. Pressure ulcers 5.5.2.3.1. Pressure ulcers market estimates and forecast 2018 to 2030 (USD Million) 5.5.2.4. Venous leg ulcers 5.5.2.4.1. Venous leg ulcers market estimates and forecast 2018 to 2030 (USD Million) 5.5.2.5. Others chronic wounds 5.5.2.5.1. Others chronic wounds market estimates and forecast 2018 to 2030 (USD Million) Chapter 6. U.S. Wound Care Devices: End-Use Estimates & Trend Analysis 6.1. Definitions and Scope 6.1.1. Hospitals 6.1.2. Outpatient facilities 6.1.3. Home care 6.1.4. Research & manufacturing 6.2. End Use Market Share, 2018 & 2030 6.3. Segment Dashboard 6.4. U.S. Wound Care Market by End-use Outlook 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 6.5.1. Hospitals 6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million) 6.5.2. Outpatient facilities 6.5.2.1. Outpatient facilities centers market estimates and forecast 2018 to 2030 (USD Million) 6.5.3. Home care 6.5.3.1. Home care market estimates and forecast 2018 to 2030 (USD Million) 6.5.4. Research & manufacturing 6.5.4.1. Research & manufacturing market estimates and forecast 2018 to 2030 (USD Million) Chapter 7. U.S. Wound Care Devices: Mode of Purchase Estimates & Trend Analysis 7.1. Definitions and Scope 7.1.1. Prescribed 7.1.2. Non-prescribed (OTC) 7.2. Mode of Purchase Market Share, 2018 & 2030 7.3. Segment Dashboard 7.4. U.S. Wound Care Market by Mode of Purchase Outlook 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 7.5.1. Prescribed 7.5.1.1. Prescribed market estimates and forecast 2018 to 2030 (USD Million) 7.5.2. Non-prescribed (OTC) 7.5.2.1. Non-prescribed (OTC) market estimates and forecast 2018 to 2030 (USD Million) Chapter 8. U.S. Wound Care Devices: Distribution Channel Estimates & Trend Analysis 8.1. Definitions and Scope 8.1.1. Institutional sales 8.1.2. Retail sales 8.2. Distribution Channel Market Share, 2018 & 2030 8.3. Segment Dashboard 8.4. U.S. Wound Care Market by Distribution Channel Outlook 8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following 8.5.1. Institutional sales 8.5.1.1. Institutional sales market estimates and forecast 2018 to 2030 (USD Million) 8.5.2. Retail sales 8.5.2.1. Retail sales market estimates and forecast 2018 to 2030 (USD Million) Chapter 9. Competitive Landscape 9.1. Recent Developments & Impact Analysis, By Key Market Participants 9.2. Company/Competition Categorization 9.2.1. Innovators 9.3. Vendor Landscape 9.3.1. List of key distributors and channel partners 9.3.2. Key customers 9.3.3. Key company market share analysis, 2023 9.3.4. Smith & Nephew PLC 9.3.4.1. Company overview 9.3.4.2. Financial performance 9.3.4.3. Product benchmarking 9.3.4.4. Strategic initiatives 9.3.5. Mölnlycke Health Care AB 9.3.5.1. Company overview 9.3.5.2. Financial performance 9.3.5.3. Product benchmarking 9.3.5.4. Strategic initiatives 9.3.6. ConvaTec Group PLC 9.3.6.1. Company overview 9.3.6.2. Financial performance 9.3.6.3. Product benchmarking 9.3.6.4. Strategic initiatives 9.3.7. Baxter International 9.3.7.1. Company overview 9.3.7.2. Financial performance 9.3.7.3. Product benchmarking 9.3.7.4. Strategic initiatives 9.3.8. URGO Medical 9.3.8.1. Financial performance 9.3.8.2. Product benchmarking 9.3.8.3. Strategic initiatives 9.3.9. Coloplast Corp. 9.3.9.1. Company overview 9.3.9.2. Financial performance 9.3.9.3. Product benchmarking 9.3.9.4. Strategic initiatives 9.3.10. Medtronic 9.3.10.1. Company overview 9.3.10.2. Financial performance 9.3.10.3. Product benchmarking 9.3.10.4. Strategic initiatives 9.3.11. 3M 9.3.11.1. Company overview 9.3.11.2. Financial performance 9.3.11.3. Product benchmarking 9.3.11.4. Strategic initiatives 9.3.12. Derma Sciences (Integra LifeSciences) 9.3.12.1. Company overview 9.3.12.2. Financial performance 9.3.12.3. Product benchmarking 9.3.12.4. Strategic initiatives 9.3.13. Medline Industries, Inc. 9.3.13.1. Company overview 9.3.13.2. Financial performance 9.3.13.3. Product benchmarking 9.3.13.4. Strategic initiatives 9.3.14. 3M 9.3.14.1. Company overview 9.3.14.2. Financial performance 9.3.14.3. Product benchmarking 9.3.14.4. Strategic initiatives 9.3.15. Ethicon (Johnson & Johnson) 9.3.15.1. Company overview 9.3.15.2. Financial performance 9.3.15.3. Product benchmarking 9.3.15.4. Strategic initiatives 9.3.16. B. Braun SE 9.3.16.1. Company overview 9.3.16.2. Financial performance 9.3.16.3. Product benchmarking 9.3.16.4. Strategic initiatives 9.3.17. Cardinal Health, Inc. 9.3.17.1. Company overview 9.3.17.2. Financial performance 9.3.17.3. Product benchmarking 9.3.17.4. Strategic initiatives 9.3.18. Organogenesis Inc 9.3.18.1. Company overview 9.3.18.2. Financial performance 9.3.18.3. Product benchmarking 9.3.18.4. Strategic initiatives 9.3.19. MIMEDX Group, Inc. 9.3.19.1. Company overview 9.3.19.2. Financial performance 9.3.19.3. Product benchmarking 9.3.19.4. Strategic initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療機器)の最新刊レポート
Grand View Research社の医療機器分野での最新刊レポート
本レポートと同じKEY WORD(channel)の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |